Akums Drugs Raises Rs 828 Crore From Anchor Investors Prior To IPO Launch
Akums Drugs and Pharmaceuticals Ltd. has raised Rs 828 crore from anchor investors, ahead of its initial public offering. The company allotted 1.22 crore shares at Rs 679 apiece to 50 anchor investors.
SBI Healthcare Opportunities Fund got the highest allocation of 7.84%. International Growth and Income Fund and Small Cap World Fund, INC got 6.33% stake in the pharmaceutical contract development and manufacturing organisation. Abu Dhabi Investment Authority-Monsoon got 6.03% stake in the company.
Nine domestic mutual funds have applied through a total of 24 schemes, Akums Drugs And Pharmaceuticals said in an exchange filing on Monday. They have collectively netted 34.21% of the anchor portion of Rs 283 crore.
SBI, Aditya Birla Sun Life, Motilal Oswal, Bandhan Small Cap Fund and Franklin India were among the top fund houses in this category.
The leading book managers for the anchor round were ICICI Securities Ltd., Axis Capital Ltd., Citigroup Global Markets India Pvt., and Ambit Pvt.
The company will launch its initial public offering on Tuesday to raise up to Rs 1,856.74 crore.
The company has set a price band of Rs 646-679 per share for its three-day IPO, consisting of fresh issue of 1 crore shares and an offer for sale of 1.73 crore shares. The minimum application lot size is 22 shares.
The offer, which concludes on Thursday, is set to list on the BSE and the National Stock Exchange.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
